RT Journal Article
SR Electronic
T1 Ageing Biomarkers Derived From Retinal Imaging: A Scoping Review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.13.24302673
DO 10.1101/2024.02.13.24302673
A1 Grimbly, Michaela
A1 Koopowitz, Sheri-Michelle
A1 Chen, Alice Ruiye
A1 Sun, Zihan
A1 Foster, Paul
A1 He, Mingguang
A1 Stein, Dan J.
A1 Ipser, Jonathan
A1 Zhu, Lisa Zhuoting
YR 2024
UL http://medrxiv.org/content/early/2024/02/14/2024.02.13.24302673.abstract
AB Background/Aims The emerging concept of retinal age, a biomarker derived from retinal images, holds promise in estimating biological age. The retinal age gap (RAG) represents the difference between retinal age and chronological age which serves as an indicator of deviations from normal ageing. This scoping review aims to collate studies on retinal age to determine its potential clinical utility and to identify knowledge gaps for future research.Methods Using the PRISMA checklist, eligible non-review, human studies were identified, selected, and appraised. Pubmed, Scopus, SciELO, PsycINFO, Google Scholar, Cochrane, CINAHL, Africa Wide EBSCO, MedRxiv, and BioRxiv databases were searched to identify literature pertaining to retinal age, the RAG, and their associations. No restrictions were imposed on publication date.Results Thirteen articles published between 2022 and 2023 were analysed, revealing four models capable of determining biological age from retinal images. Three models, ‘Retinal Age’, ‘EyeAge’ and a ‘convolutional network-based model,’ achieved comparable mean absolute errors (MAE): 3.55, 3.30 and 3.97 respectively. A fourth model, ‘RetiAGE’, predicting the probability of being older than 65 years, also demonstrated strong predictive ability with respect to clinical outcomes. In the models identified, a higher predicted RAG demonstrated an association with negative occurrences, notably mortality and cardiovascular health outcomes.Conclusion This review highlights the potential clinical application of retinal age and RAG, emphasising the need for further research to establish their generalisability for clinical use, particularly in neuropsychiatry. The identified models showcase promising accuracy in estimating biological age, suggesting its viability for evaluating health status.What is already known on this topic Retinal age has emerged as a promising ageing biomarker capable of determining biological age from retinal images.What this study adds This study presents a comprehensive scoping review of current literature concerning retinal age and the RAG, highlighting the reproducible association between advanced retinal age gap and increased mortality and cardiovascular disease risk.How this study might affect research, practice, or policy The findings underscore the paucity of knowledge on this topic, advocating for further research in this area to determine the potential clinical use of retinal age as a biomarker.Synopsis This scoping review explores retinal age, a biological ageing marker derived from retinal images. Findings from 13 articles reveal links between advanced retinal ageing gaps and adverse outcomes, emphasizing its potential for improving health outcomes.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://osf.io/fse75/ Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript